Naixi Wu sells shares under 10b5-1 plan (INDI) reported Apr–Jun 2026

Rhea-AI Filing Summary

Naixi Wu reported multiple sales of Common Stock under Rule 144/10b5-1 plans. The filing lists sales on 04/06/2026 (5,876 shares, $17,547.50), 04/09/2026 (55,000 shares, $154,561.00), 06/01/2026 (6,000 shares, $29,662.80), and 06/02/2026 (12,898 shares, $65,997.78). The transactions are identified as 10b5-1 sales and appear as routine dispositions reported on the notice form.

Insights

Corporate Governance Specialist

Multiple scheduled 10b5-1 sales reported by Naixi Wu across April–June 2026.

These entries list specific share counts and proceeds: $17,547.50 for 5,876 shares on 04/06/2026, $154,561.00 for 55,000 shares on 04/09/2026, $29,662.80 for 6,000 shares on 06/01/2026, and $65,997.78 for 12,898 shares on 06/02/2026. The filings label these as 10b5-1 sales, indicating pre-arranged trading plans.

The practical implication is procedural: these are reported dispositions under a trading plan rather than discretionary open-market trades. Cash‑flow treatment and any remaining holdings after these transactions are not detailed in the provided excerpt; subsequent filings would show post-transaction positions if reported.

Key Figures

Sale on 04/09/2026: 55,000 shares Sale on 06/02/2026: 12,898 shares Sale on 06/01/2026: 6,000 shares +1 more

4 metrics

Sale on 04/09/2026 55,000 shares proceeds <money>$154,561.00</money>

Sale on 06/02/2026 12,898 shares proceeds <money>$65,997.78</money>

Sale on 06/01/2026 6,000 shares proceeds <money>$29,662.80</money>

Sale on 04/06/2026 5,876 shares proceeds <money>$17,547.50</money>

Key Terms

10b5-1, Form 144, Restricted Stock Awards

3 terms

10b5-1 regulatory

"10b5-1 Sales for NAIXI WU 32 JOURNEY Aliso Viejo CA 92656"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Awards financial

"Common | 12/22/2021 | Restricted Stock Awards"

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/02/2026 - 04:34 PM Accepted by SEC EDGAR 07/02/2026 - 04:33 PM Learn about SEC filing dates

FAQ

What transactions did Naixi Wu report in the Form 144 for INDI?

The filing reports four sales: 5,876 shares on 04/06/2026 ($17,547.50), 55,000 shares on 04/09/2026 ($154,561.00), 6,000 shares on 06/01/2026 ($29,662.80), and 12,898 shares on 06/02/2026 ($65,997.78).

Were the sales reported by Naixi Wu made under a trading plan?

Yes. The transactions in the excerpt are described as 10b5-1 sales, indicating they were effected under pre-arranged trading plans rather than ad hoc discretionary trades.

Does the Form 144 excerpt show proceeds received from these sales?

Yes. The excerpt lists proceeds for each sale: for example, $154,561.00 for 55,000 shares on 04/09/2026 and $65,997.78 for 12,898 shares on 06/02/2026 as shown in the filing.

Who is the reporting person and what security was sold?

The reporting person is Naixi Wu, and the security sold in the listed transactions is Common Stock of the issuer identified in the excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25640	116405.60	211288591	07/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/22/2021	Restricted Stock Awards	Issuer			25640	12/22/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
NAIXI WU 32 JOURNEY Aliso Viejo CA 92656	Common	06/02/2026	12898	65997.78
10b5-1 Sales for NAIXI WU 32 JOURNEY Aliso Viejo CA 92656	Common	06/01/2026	6000	29662.80
10b5-1 Sales for NAIXI WU 32 JOURNEY Aliso Viejo CA 92656	Common	04/09/2026	55000	154561.00
NAIXI WU 32 JOURNEY Aliso Viejo CA 92656	Common	04/06/2026	5876	17547.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)